Phil Garner has over 22 years of STM publishing experience, working in leadership roles and across many functions, with a track record in developing and implementing change to improve productivity, growing top- and bottom-line results, and doing so whilst motivating and getting buy-in from staff.
Phil is Co-Founder & CEO of Becaris Publishing Limited, the publisher of the Journal of Comparative Effectiveness Research and The Evidence Base. The company is currently in the process of a flip from a subscription/hybrid model to open access.
Since 2017, Phil has served as a Non-Executive Director at Portland Press Limited, the publishing arm of the Biochemical Society, where he has been pivotal in steering the portfolio on a path to full and immediate open access.
Previous roles include CEO of the STM publisher Future Science Group (FSG), where, for over 8.5 years, Phil led the business from being a small, traditional publishing company underpinned by subscriptions, to something much more varied, innovative, commercially successful, and engaging for authors and readers. This included the launch of FSG’s Read & Publish license in 2019 and the successful development and implementation of numerous new revenue streams to lessen the reliance on subscriptions.
Prior to that, Phil spent a decade at Informa plc/Taylor & Francis in senior positions, including Divisional Managing Director of medical books and journals, and working on numerous acquisitions and integrations.
Phil is a mentor with ALPSP, and a member of the Training Committee.